Objective: Epilepsy is a disease characterized by chronic seizures, but is associated with significant comorbidities between seizures including cognitive impairments, hyperactivity, and depression. To study this interictal state, we characterized the electrical, molecular, and behavior effects of chronic, neocortical interictal spiking in rats. Methods: A single injection of tetanus toxin into somatosensory cortex generated chronic interictal spiking measured by long-term video EEG monitoring and was correlated with motor activity. The cortical pattern of biomarker activation and the effects of blocking MAPK signaling on interictal spiking and behavior were determined. Results: Interictal spiking in this model increases in frequency, size, and becomes repetitive over time, but is rarely associated with seizures. Interictal spiking was sufficient to produce the same molecular and cellular pattern of layer 2/3-specific CREB activation and plasticity gene induction as is seen in the human interictal state. Increasing spike frequency was associated with hyperactivity, demonstrated by increased ambulatory activity and preferential circling toward the spiking hemisphere. Loud noises induced epileptic discharges, identical to spontaneous discharges. Treatment with a selective MAPK inhibitor prevented layer 2/3 CREB activation, reduced the frequency of epileptic discharges, and normalized behavioral abnormalities, but had no effect on seizures induced by electrical kindling. Interpretation: These results provide insights into the development of interictal epileptic spiking, their relationship to behavior, and suggest that interictal and ictal activities utilize distinct molecular pathways. This model, that parallels recent observations in humans, will be useful to develop therapeutics against interictal spiking and its behavioral comorbidities.
Introduction
Epilepsy is a disease of recurrent seizures which occurs in 0.4-1.0% of the world population (Annegers, 1993; Hirtz et al., 2007; Sander, 2003) . The relationship of interictal spiking to seizures remains poorly understood. Human studies (Gotman, 1991; Lange et al., 1983; Lieb et al., 1978) and in vitro preparations (de Curtis and Avanzini, 2001) suggest that interictal spikes may be protective against seizures. However, interictal spikes are frequently highest in the same areas of brain that produce seizures and are used to identify epileptic brain regions for resections (Asano et al., 2003; Holmes et al., 2000; Marsh et al., 2010) . Removing areas of high spike activity is in fact associated with a reduction of seizures (Bautista et al., 1999; McBride et al., 1991) . In addition to seizures, patients with epilepsy experience a variety of comorbid conditions, such as AttentionDeficit Hyperactivity Disorder (ADHD) and other psychiatric conditions (Garcia-Morales et al., 2008) . Because 'ictal' seizures are relatively brief and infrequent, patients with epilepsy are more often in the 'interictal' state. One possibility is that interictal spikes contribute to both epileptogenesis and behavioral comorbidities (Staley et al., 2011) . Interictal spikes have been observed in ADHD even without seizures (Fonseca et al., 2008; Richer et al., 2002; Silvestri et al., 2007) and improved behavior is noted in patients with reduced interictal spiking (Pressler et al., 2005) .
Recent genome-wide expression studies show a highly consistent pattern of layer 2/3-specific MAPK-CREB signaling and downstream gene activations in the interictal human epileptic neocortex (Rakhade et al., 2005; Beaumont et al., unpublished results) . Many of these changes in human cortex vary directly in proportion to the degree of Neurobiology of Disease 47 (2012) 92-101 
